Posted by admin | Posted in Health Care, Pharmacies | Posted on 15-09-2009
World Health Organization WHO (World Health Organization) said that antiviral drugs should not be used to prevent influenza A-H1N1 although most cases of drug resistance was associated with treatment before the infection.
“The risk of resistance appears more common in people taking oseltamivir for prevention purposes after the close and although the infected patients taking oseltamivir,” the UN official explained in a statement.
Oseltamivir is commonly known by the trade name Tamiflu is the drug recommended by WHO to deal with the A-H1N1 flu. The UN says that 12 of 28 cases of Tamiflu resistance is associated with the use intended for the prevention. Read the rest of this entry »
